• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants

tetano

Editor, Senior Moderator
Nat Commun


. 2024 Sep 4;15(1):7715.
doi: 10.1038/s41467-024-51973-8. Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants

Haonan Yang[SUP] #[/SUP][SUP] 1 [/SUP], Huimin Guo[SUP] #[/SUP][SUP] 2 [/SUP], Aojie Wang[SUP] #[/SUP][SUP] 1 3 [/SUP], Liwei Cao[SUP] #[/SUP][SUP] 4 [/SUP], Qing Fan[SUP] 2 [/SUP], Jie Jiang[SUP] 2 [/SUP], Miao Wang[SUP] 2 [/SUP], Lin Lin[SUP] 5 [/SUP], Xiangyang Ge[SUP] 2 [/SUP], Haiyan Wang[SUP] 2 [/SUP], Runze Zhang[SUP] 1 [/SUP], Ming Liao[SUP] 6 7 [/SUP], Renhong Yan[SUP] 8 [/SUP], Bin Ju[SUP] 9 10 [/SUP], Zheng Zhang[SUP] 11 12 13 [/SUP]



Affiliations
Abstract

The Omicron subvariants of SARS-CoV-2, especially for BA.2.86 and JN.1, have rapidly spread across multiple countries, posing a significant threat in the ongoing COVID-19 pandemic. Distinguished by 34 additional mutations on the Spike (S) protein compared to its BA.2 predecessor, the implications of BA.2.86 and its evolved descendant, JN.1 with additional L455S mutation in receptor-binding domains (RBDs), are of paramount concern. In this work, we systematically examine the neutralization susceptibilities of SARS-CoV-2 Omicron subvariants and reveal the enhanced antibody evasion of BA.2.86 and JN.1. We also determine the cryo-EM structures of the trimeric S proteins from BA.2.86 and JN.1 in complex with the host receptor ACE2, respectively. The mutations within the RBDs of BA.2.86 and JN.1 induce a remodeling of the interaction network between the RBD and ACE2. The L455S mutation of JN.1 further induces a notable shift of the RBD-ACE2 interface, suggesting the notably reduced binding affinity of JN.1 than BA.2.86. An analysis of the broadly neutralizing antibodies possessing core neutralizing epitopes reveals the antibody evasion mechanism underlying the evolution of Omicron BA.2.86 subvariant. In general, we construct a landscape of evolution in virus-receptor of the circulating Omicron subvariants.


 
Back
Top Bottom